Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 3Phase 4 2Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1CNS 1

Conditions

Polyps 1Patient Satisfaction 1Neurofibromatoses 1Neoplasms 1Hydrocephalus 1Headache 1Epilepsy 1Colonic Neoplasms 1Abdominal Neoplasms 1

Interventions

Saline Solution 10Docetaxel 10Bevacizumab 9nilotinib 8enzalutamide 8Paclitaxel 8Letrozole 8Fentanyl 8Everolimus 8Cyclophosphamide 8Carboplatin 8Bupivacaine 8Lidocaine 7Sodium Chloride 6Oxycodone 6Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 6Erlotinib Hydrochloride 6Dexamethasone 6Capecitabine 6Trastuzumab 5Tobacco Use Cessation Devices 5Surveys and Questionnaires 5Nivolumab 5Hydromorphone 5Adalimumab 5fludarabine 4Zoledronic Acid 4Tranexamic Acid 4Tacrolimus 4Rocuronium 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Has results × Propofol × Clear all
NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Medical College of Wisconsin

Phase 4 Completed
40 enrolled 15 charts
CNS

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

NCT02937506 2017-12-26

Patient Satisfaction With Propofol for Out Patient Colonoscopy

Mount Carmel Health System

Phase 4 Completed
600 enrolled 5 charts
Gastrointestinal

Colonic Neoplasms, Polyps, Patient Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡